High-dose vitamin C reduces inflammation in cancer patients, study shows

The value and impact of a daily vitamin C supplement as well as high, concentrated doses for acute illnesses is becoming increasingly clear. Studies have already shown the efficacy of liposomal vitamin C in treating infections and as an anti-cancer therapy.  Now, another study is confirming its effectiveness against inflammation in cancer patients, one of the primary markers.

Over the past 35 years, the Riordan Clinic has had quite a bit of experience in administering extremely high doses of vitamin C to cancer patients. These tests for vitamin C have been conducted due to its proven value as a therapeutic and preventative measure.

Markers of inflammation such as pro-inflammatory cytokines and C-reactive protein tumor markers showed a positive response to vitamin C treatments, with inflammation reduced significantly. This improvement correlated with reduced tumor size and the hindrance of the cancer’s ability to metastasize.

This research was conducted by Riordan Clinic scientists and published in the Journal of Translational Medicine. When supplementing with liposomal vitamin C orally for major health issues, 10,000 to 12,000 mg per day should be taken. This dose can be taken in 2,000 to 4,000 mg doses gradually throughout the day to aid absorption.

Editor’s note: Our advise remains the same.  Whenever dealing with a life-threatening condition, like cancer – always consult a trusted, medical professional to help guide you in the recovery process.


Read the rest of the article at: http://www.naturalhealth365.com/vitamin-c-inflammation-2045.html

You just earned points!
Login to save points.
Earn your spot on the leaderboard.

You earned Health Freedom Idaho points!

You're on your way to the top of the leaderboard!